| Nephrocare Health Services Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 544647 |
NSE Symbol : NEPHROPLUS |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE428V01029 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 90.58 |
Market Cap(₹Cr) : 7,365.01 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 164.33 | 160.66 | 155.92 | 148.83 | 145.01 | 138.21 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 164.33 | 160.66 | 155.92 | 148.83 | 145.01 | 138.21 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 6.14 | 3.46 | 2.87 | 2.97 | 2.73 | 3.91 |
| Total Income | 170.47 | 164.13 | 158.79 | 151.80 | 147.74 | 142.12 |
| Total Expenditure | 142.26 | 137.80 | 132.45 | 129.08 | 123.26 | 115.75 |
| PBIDT | 28.21 | 26.33 | 26.34 | 22.72 | 24.48 | 26.36 |
| Interest | 1.27 | 3.96 | 41.05 | 3.48 | 3.68 | 3.40 |
| PBDT | 26.94 | 22.37 | -14.71 | 19.24 | 20.80 | 22.96 |
| Depreciation | 15.95 | 13.41 | 15.91 | 12.35 | 13.39 | 12.17 |
| Tax | 3.91 | 3.07 | 4.48 | 2.67 | 2.43 | 3.60 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -3.80 | -2.56 | -2.68 | -0.78 | -0.68 | -0.92 |
| Reported Profit After Tax | 10.89 | 8.45 | -32.41 | 5.01 | 5.67 | 8.12 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 10.89 | 8.45 | -32.41 | 5.01 | 5.67 | 8.12 |
| EPS (Unit Curr.) | 1.09 | 0.90 | -3.82 | 0.50 | 0.70 | 1.00 |
| EPS (Adj) (Unit Curr.) | 1.09 | 0.90 | -3.82 | 0.50 | 0.70 | 1.00 |
| Calculated EPS (Unit Curr.) | 1.09 | 0.84 | -17.91 | 0.50 | 6.43 | 9.20 |
| Calculated EPS (Adj) (Unit Curr.) | 1.09 | 0.84 | -17.91 | 0.50 | 6.43 | 9.20 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.34 | 3.37 | -71.65 | 2.00 | 25.71 | 36.80 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.34 | 3.37 | -71.65 | 2.00 | 25.71 | 36.80 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 20.07 | 20.07 | 3.62 | 20.07 | 1.77 | 1.76 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.17 | 16.39 | 16.89 | 15.27 | 16.88 | 19.07 |
| PBDTM(%) | 16.39 | 13.92 | -9.43 | 12.93 | 14.34 | 16.61 |
| PATM(%) | 6.63 | 5.26 | -20.79 | 3.37 | 3.91 | 5.88 |
